Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products.
Today’s technology has the potential to empower independent pharmacies to offer adherence support at a greater scale — and healthcare engagements that overlook this touchpoint miss out.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Over the past 15 years, financial and administrative barriers – most notably step therapy mandates and prior authorization requirements – have repeatedly forced patients through suboptimal or ineffective treatments before they can try another therapy, have tied the hands of healthcare professionals and patients alike. Now there's a possible solution.
Utah is piloting an AI system developed by Doctronic to autonomously handle routine prescription refills, aiming to reduce delays and boost medication adherence. But a report from Mindgard AI claiming that there are vulnerabilities in the company’s chatbot underscores the broader challenge regulators and developers face in ensuring healthcare AI systems remain safe and reliable in real-world use.
Congress has already granted the FDA flexibility in evaluating therapies for rare diseases, including the use of real-world evidence and natural history data when traditional large-scale trials are not feasible. The question before the FDA now is not if those tools can be applied – they can – but if the agency has the courage to use them before more patients lose their autonomy, and ultimately, their lives, to rare disease.
In the latest episode of the Debunked Podcast, the discussion revolved around the Break Up Big Medicine legislation to rein in healthcare giants and ways to introduce meaningful PBM reform.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
It’s time to break down the myths holding the pharmacy sector back, and the emerging realities shaping a new, tech-enabled approach to adherence that blends operational redesign, AI innovation and equity-focused care.
Polypharmacy is a cost and safety problem that is solvable. The right technology platform can reduce it by identifying risky regimens, route specific “stop/switch/consolidate” opportunities to clinicians, and track whether changes stick through refill and adherence patterns.
Investing in modern, tech-enabled staffing solutions is not just about filling shifts; it’s about building more resilient organizations that anticipate labor demands, prioritize patient care, and achieve sustainable financial health.
Any regulations applied won’t be as simple as putting on a Band-Aid and forgetting about future problems. To regulate appropriately, we need to learn from the past and act quickly as AI is rapidly incorporated into healthcare.
How to turn analytics into actual policy outcomes.
Here are some of the structural and strategic causes behind that failure rate, and ways to improve launch outcomes.
By embracing innovation, optimizing operations and advocating for change, pharmacy leaders can ensure their organizations are not only prepared for the future but are actively shaping it.
HHS is scrapping its proposed 340B rebate pilot after hospitals sued to stop it. Providers say the plan would have created cash flow problems and administrative burdens that threatened safety-net care.
At a time when 98 million prescriptions are abandoned due to cost surprises, it’s critical that all four categories of prescription drug prices are available so consumers can determine how to obtain needed medications at the lowest cost.
January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, Aidoc, Suki and Particle Health named new executives. There were also layoffs at organizations including Takeda, Trinity Health and Horizon BCBS New Jersey.